Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 15:13:1375-1389.
doi: 10.2147/PPA.S213258. eCollection 2019.

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States

Shannon O Armstrong  1 , Richard A Little  2   3
Affiliations

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States

Shannon O Armstrong et al. Patient Prefer Adherence. .

Abstract

Introduction: Cardiovascular disease (CVD) is the leading cause of death in the United States, and high cholesterol is a leading risk factor for CVD. While statins are effective at reducing cholesterol, they are frequently underused in patients at highest risk of CVD. The objective of this study was to identify interventions which may improve adherence to statins and to assess their cost effectiveness within the US Medicare population.

Methods: A literature review was undertaken to identify interventions to improve adherence in patients with CVD at highest risk of a recurrent event and to quantify non-adherence and the consequences of non-adherence to statins in this population. A Markov cost-utility model was developed to assess the cost effectiveness of these interventions.

Results: Ten adherence interventions were identified in the literature, with 6 demonstrating statistically significant improvement in adherence. The six interventions were disease management, interactive voice response, nurse counselling, discharge letter, nurse/dietician counselling and electronic pill bottle with feedback. The model found the cost effectiveness of an intervention was highly dependent on its effectiveness and costs. Incremental cost effectiveness ratios ranged from $27,545/QALY for discharge letter with large adherence gain to $130,399/QALY for disease management program with small adherence gain.

Conclusion: Some interventions to improve adherence have been shown to be effective, but little attention has been paid to the costs. Further studies on adherence interventions should include economic evaluations.

Keywords: adherence; cardiovascular disease; cost-effectiveness; statins.

PubMed Disclaimer

Conflict of interest statement

Ms. Shannon Armstrong is an employee and shareholder of the Medicines Company. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Model schematics of decision tree and Markov transitions.
Figure 2
Figure 2
Diagram of searches and study inclusion selection.
Figure 3
Figure 3
One-way sensitivity analysis.
Figure 4
Figure 4
Cost effectiveness plane for electronic pill bottle intervention.
Figure 5
Figure 5
Cost effectiveness acceptability curves for interventions.
See this image and copyright information in PMC

References

    1. Khavjou O, Phelps D, Leib A. Cardiovascular disease burden: a costly burden for America. Am Heart Assoc. 2016.
    1. Centers for Disease Control and Prevention. Heart Disease Facts. https://www.cdc.gov/heartdisease/facts.htm. Accessed October 3, 2016.
    1. Centers for Disease Control and Prevention. High Cholesterol in the United States. http://www.cdc.gov/cholesterol/facts.htm. Accessed October3, 2016.
    1. Baigent C, Keech A, Kearney PM, et al.; Cholesterol Treatment Trialists (CCT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–1278. doi: 10.1016/S0140-6736(05)67394-1 - DOI - PubMed
    1. Consumer Reports. Best Buy Drugs: Evaluating Statin Drugs to Treat High Cholesterol and Heart Disease. New York, NY: Consumer Reports;2014.

LinkOut - more resources